Kanaji, N.; Watanabe, N.; Inoue, T.; Mizoguchi, H.; Komori, Y.; Ohara, Y.; Kadowaki, N.
Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease. J. Pers. Med. 2025, 15, 115.
https://doi.org/10.3390/jpm15030115
AMA Style
Kanaji N, Watanabe N, Inoue T, Mizoguchi H, Komori Y, Ohara Y, Kadowaki N.
Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease. Journal of Personalized Medicine. 2025; 15(3):115.
https://doi.org/10.3390/jpm15030115
Chicago/Turabian Style
Kanaji, Nobuhiro, Naoki Watanabe, Takuya Inoue, Hitoshi Mizoguchi, Yuta Komori, Yasuhiro Ohara, and Norimitsu Kadowaki.
2025. "Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease" Journal of Personalized Medicine 15, no. 3: 115.
https://doi.org/10.3390/jpm15030115
APA Style
Kanaji, N., Watanabe, N., Inoue, T., Mizoguchi, H., Komori, Y., Ohara, Y., & Kadowaki, N.
(2025). Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease. Journal of Personalized Medicine, 15(3), 115.
https://doi.org/10.3390/jpm15030115
